GLYCOVISION

Platform as a Service (PAAS) featuring computer software platforms for medical and scientific research, identifying biomarkers for diseases, drug discovery, glycoproteomic research and analysis and reporting, and medical and scientific laboratory services; scientific and medical research services; scientific research, namely, identifying biomarkers for specific diseases; scientific research analysis services for blood and other bodily fluids, specifically, blood, bodily fluid, and biological specimen analysis services; scientific, technological, and medical research and data analysis services in the nature of bioanalytical testing services and biomarker discovery services; scientific and medical research in the fields of oncology, mass spectrometry, cellular analysis, glycoproteomics, biomarker discovery, and drug discovery; scientific, technological, and data analysis services, namely, glycoproteomic research, analysis services in the nature of protein and cellular analyses, and a glycoproteomic solution featuring artificial intelligence; scientific and medical laboratory services; medical research services via collecting, analyzing, and reporting glycoproteomic data for blood, bodily fluids, and other biological specimens